Premature Ejaculation Treatment Market Forecast 2025–2034: Trends Reshaping Demand, Investment, and Innovation
Discover trends, market shifts, and competitive outlooks for the prenatal and newborn genetic testing industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
How Fast Is The Prenatal And Newborn Genetic Testing Market Expected to Grow Between 2025 And 2029?
The market size for genetic testing for newborns and pregnant women has seen rapid expansion in recent times. It is anticipated to increase from $6.68 billion in 2024 to $7.61 billion in 2025, marking a consistent compound annual growth rate (CAGR) of 13.9%. The growth witnessed in the past years can be credited to advancements in non-invasive prenatal testing, a rise in maternal age, governmental support and healthcare policies promoting such tests, and the demand from patients for early detection.
The market for prenatal and newborn genetic testing is projected to experience significant expansion in the coming years, with its value expected to reach $12.04 billion in 2029, marking an annual average growth rate of 12.1%. This growth during the forecast period can be linked to factors such as an increase in genetic test panels, heightened awareness of maternal health, guidelines for prenatal and newborn screening, concentrated attention on rare diseases, as well as ethical and regulatory considerations. Some of the major trends anticipated within this period include non-invasive prenatal testing (NIPT), genome sequencing (WGS) and whole exome sequencing, the incorporation of artificial intelligence (AI), preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Prenatal And Newborn Genetic Testing Market?
The upswing in the prenatal and newborn genetic testing markets is projected to be powered by government initiatives and backing for prenatal assessments and neonatal genetic screening. These governmental actions, be it at the local, regional or national level, focus on addressing specific issues, reaching definite goals, or enhancing their citizens’ welfare. Such initiatives involving prenatal and newborn genetic tests aid society by detecting genetic disorders or anomalies in fetuses during gestation or in newborns right after their birth. For instance, the Australian government, in June 2022, committed annual funding of $1.3 million to the New South Wales (NSW) newborn screening program. This initiative aims to offer complimentary tests for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA) via newborn genetic tests and screenings to all newborns in the state. These screenings, targeting around 100,000 babies annually, could potentially save up to 13 newborns prone to these genetic irregularities. Hence, such government-provided initiatives and support fuel the growth of the prenatal and newborn genetic testing markets. The Prenatal And Newborn Genetic Testing Market is poised for further growth, driven primarily by an increase in genetic disorder rates. Genetic disorders, resulting from DNA abnormalities or genetic material mutations, constitute medical conditions that can be detected early on by prenatal and newborn genetic assessments. This early-stage identification often precedes symptom development, allowing for immediate initiation of medical interventions and treatment plans. To illustrate, the Centers for Disease Control and Prevention (CDC), in May 2024, reported that sickle cell disease (SCD) affects roughly 100,000 individuals in the US, the majority of whom are non-Hispanic Black or African American, with an estimated 3%-9% Hispanic or Latino population. Thus, the escalating prevalence of such genetic disorders propels the growth of the prenatal and newborn genetic testing market.
Which Primary Segments of the Prenatal And Newborn Genetic Testing Market Are Driving Growth and Industry Transformations?
The prenatal and newborn genetic testing market covered in this report is segmented –
1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers
Subsegments:
1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=13158&type=smp
Which Regions Are Key Players in the Growth of the Prenatal And Newborn Genetic Testing Market?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Most Significant Market Trends in the Prenatal And Newborn Genetic Testing Market?
Leading businesses in the newborn and prenatal genetic testing markets are concentrating on the creation of innovative screening methods, such as noninvasive prenatal screening exams, in an effort to increase their accessibility and affordability, while delivering reliable services to their clientele. Noninvasive prenatal testing (NIPT), also referred to as noninvasive prenatal screening (NIPS), is a sophisticated, safe technique for genetic screening during pregnancy that evaluates the risk of predetermined fetal chromosome irregularities. For instance, Juno Diagnostics Inc., a healthcare technology enterprise based in the U.S., introduced Juno Hazel in November 2022. This noninvasive prenatal screening test identifies chromosome anomalies and includes clinical content. It makes use of a sample collection kit, negating the requirement for phlebotomy and thereby enhancing accessibility. The company aims to provide educational resources and custom genetic counseling assistance by collaborating with physicians and genetic counselors.
View the full report here:
What Parameters Are Used to Define the Prenatal And Newborn Genetic Testing Market?
Prenatal and newborn genetic testing refers to the medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are performed to detect and identify genetic disorders, congenital conditions, or hereditary diseases that may affect the child’s health or development.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
